Ann: June 2019 Quarterly Activities and Cashflow Reports, page-6

I personally would like to know more about this strategy...

“We have a clear strategy in place to develop and commercialise superior standardised products and to partner with healthcare professionals to develop evidence-based data and personalised treatment solutions for their patients. Our goal is to progress towards commercialisation and with our proprietary final dose form capsules developed, we look forward to having our first product line ready for clinical trials towards the end of 2019.”